Cashim

Based in China, Cashim is a medical technology company specializing in advanced tumor radiation therapy solutions for oncology. They focus on developing innovative medical equipment designed to improve cancer treatment outcomes. Founded in 2018 and headquartered in Beijing, China, Cashim operates in the medical technology sector, delivering innovative tumor radiation therapy devices. The company has engaged in one notable funding deal, raising CNY 800 million in February 2026, led by Legend Capital.

This investment aims to enhance their offerings and bolster their market presence in oncology treatment. Cashim's primary product is the 医用重离子加速器 (HIMM), a sophisticated tumor radiation therapy device developed in collaboration with the Institute of Modern Physics under the Chinese Academy of Sciences. The HIMM features a unique technology combination of a cyclotron injector and synchrotron main accelerator, delivering high-energy heavy ion beams that effectively target cancerous tissues. This innovative system is designed to minimize damage to surrounding healthy tissues, making it a compelling option for hospitals and cancer treatment centers in both domestic and international markets.

Cashim operates a B2B model, primarily selling and installing its HIMM systems to healthcare institutions specializing in oncology. Revenue is generated not only from initial equipment sales but also through comprehensive maintenance and support agreements, which include training and technical assistance. This partnership-focused approach enables Cashim to solidify its market presence while ensuring its clients can effectively implement advanced radiation therapy solutions. In February 2026, Cashim raised CNY 800 million in venture funding from Legend Capital, which will be allocated to accelerate the industrialization of multi-ion therapy systems, establish clinical centers, and pursue international registration efforts.

The company plans to expand its reach into new markets, targeting hospitals and cancer treatment centers globally as they enhance their product offerings and increase market penetration.